April 5, 2018 Acad, Gov/Utilities Bio/Pharma/CRO Lab Top-10

University of Pittsburgh and Thermo Fisher Scientific Establish Pharmacogenomics Center of Excellence

University of Pittsburgh and Thermo Fisher Scientific Establish Pharmacogenomics Center of Excellence Collaboration will support translational research that demonstrates the value of PGx in precision medicine PITTSBURGH, April 5, 2018 /PRNewswire/ — Thermo Fisher Scientific and the University of Pittsburgh have established a new Pharmacogenomics (PGx) Center of Excellence that combines expertise and technology in genomics,... Read more

March 22, 2018 Acad, Gov/Utilities

FDA approves Lucentis (ranibizumab injection) 0.3 mg prefilled syringe for diabetic macular edema and diabetic retinopathy

Basel, 22 March 2018 FDA approves Lucentis (ranibizumab injection) 0.3 mg prefilled syringe for diabetic macular edema and diabetic retinopathy First and only prefilled syringe treatment option FDA-approved to treat all forms of diabetic retinopathy in people with or without diabetic macular edema (DME) Diabetic retinopathy is the leading cause of blindness among adults aged... Read more

March 7, 2018 Acad, Gov/Utilities Informatics & Software Molecular Spectroscopy

WITec Releases TrueMatch – Integrated Raman Spectral Database Software

March 2018 TrueMatch is a powerful and innovative software component for accessing and developing Raman spectral databases WITec, manufacturer of 3D Raman imaging systems, is now offering TrueMatch, a powerful software component for accessing and creating Raman spectral databases. It can search existing libraries of Raman spectra to identify sample components and also allows users... Read more

March 5, 2018 Acad, Gov/Utilities Product Launch

QIAGEN launches CE-IVD assay to detect Trichomonas vaginalis in both female and male patients on the QIAsymphony RGQ platform

Germantown, Maryland, and Hilden, Germany, March 5th, 2018 – QIAGEN today announced the European launch of the artus T. vaginalis QS-RGQ Kit, a CE-marked molecular diagnostic test for the qualitative detection of the protozoan parasite T. vaginalis in both female and male patients. The artus T. vaginalis QS-RGQ Kit is an in vitro real-time polymerase... Read more

March 1, 2018 Acad, Gov/Utilities Lab Top-10 PR/Corporate

Bruker Names Burkhard Prause, President of Bruker Energy & Supercon Technologies (BEST), an Executive Officer of Bruker Corporation

BILLERICA, Mass., March 1, 2018 /PRNewswire/ — Bruker today announced the appointment of Dr. Burkhard Prause, the President of the Bruker Energy & Supercon Technologies (BEST) segment, as an executive officer of Bruker Corporation.  Dr. Prause has a successful track record of leading BEST through a significant expansion of its business in the last decade,... Read more

February 28, 2018 Acad, Gov/Utilities Environ, Ag./Food & Bev Lab Top-10 M&A, Partnerships

Agilent and Imperial College London Announce Collaboration Agreement

Agilent and Imperial College London Announce Collaboration Agreement Agilent Measurement Suite to provide researchers with greater experimental freedom SANTA CLARA, Calif., February 28, 2018 Agilent Technologies Inc. (NYSE: A) and Imperial College London today signed a strategic scientific collaboration agreement that brings together Agilent’s leading analytical technologies with Imperial’s outstanding researchers. Under the agreement, Agilent... Read more

February 27, 2018 Acad, Gov/Utilities

GE Healthcare to License Duke University’s CT Organ Dosimetry Technology

Milwaukee (July 31, 2017) – GE Healthcare announced today that it has licensed Computed Tomography (CT) organ dosimetry technology developed at Duke University. The technology enables automatic calculation of organ dose, helping the clinician to better estimate the radiation exposure to the patient https://www.genewsroom.com/press-releases/ge-healthcare-license-duke-universitys-ct-organ-dosimetry-technology Read more

February 27, 2018 Acad, Gov/Utilities

GE Healthcare to License Duke University’s CT Organ Dosimetry Technology

“This technology assesses organ doses in patients undergoing CT in an examination-specific manner, where granular dose estimates are precisely informed by the patient anatomy and the exact irradiation condition,” said Ehsan Samei, a professor of radiology, physics and biomedical engineering at Duke, who led development of the tool. “The technology includes a realistic estimation of... Read more

February 14, 2018 Acad, Gov/Utilities

FDA grants priority review for Roche’s MabThera/ Rituxan (rituximab) for pemphigus vulgaris

Basel, 14 February 2018 FDA grants priority review for Roche’s MabThera/ Rituxan (rituximab) for pemphigus vulgaris Pemphigus vulgaris (PV) is a life-threatening, autoimmune condition with limited treatment options1 The FDA previously granted Breakthrough Therapy Designation and Orphan Drug Designation for MabThera/Rituxan in PV Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food... Read more

February 13, 2018 Acad, Gov/Utilities Product Launch

FDA Approves New HPV Test that Detects and Identifies HPV Genotypes that put Women at High Risk for Cervical Cancer

FRANKLIN LAKES, N.J., Feb. 13, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has received pre-market approval from the U.S. Food and Drug Administration (FDA) for the BD Onclarity™ HPV assay. The test detects 14 types of high-risk human papillomavirus (HPV) from specimens collected... Read more